RU2683940C1 - Производные имидазотиазола в качестве модуляторов активности tnf - Google Patents

Производные имидазотиазола в качестве модуляторов активности tnf Download PDF

Info

Publication number
RU2683940C1
RU2683940C1 RU2016127226A RU2016127226A RU2683940C1 RU 2683940 C1 RU2683940 C1 RU 2683940C1 RU 2016127226 A RU2016127226 A RU 2016127226A RU 2016127226 A RU2016127226 A RU 2016127226A RU 2683940 C1 RU2683940 C1 RU 2683940C1
Authority
RU
Russia
Prior art keywords
group
alkyl
methyl
carboxy
optionally substituted
Prior art date
Application number
RU2016127226A
Other languages
English (en)
Russian (ru)
Other versions
RU2016127226A (ru
Inventor
Рикки Питер Александер
Мезхер Хуссейн Али
Джулиен Алистэр Браун
Виктория Элизабет Джексон
Original Assignee
Юсб Байофарма Спрл
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Юсб Байофарма Спрл filed Critical Юсб Байофарма Спрл
Publication of RU2016127226A publication Critical patent/RU2016127226A/ru
Application granted granted Critical
Publication of RU2683940C1 publication Critical patent/RU2683940C1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
RU2016127226A 2013-12-09 2014-12-08 Производные имидазотиазола в качестве модуляторов активности tnf RU2683940C1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1321731.0 2013-12-09
GBGB1321731.0A GB201321731D0 (en) 2013-12-09 2013-12-09 Therapeutic agents
PCT/EP2014/076842 WO2015086504A1 (en) 2013-12-09 2014-12-08 Imidazothiazole derivatives as modulators of tnf activity

Publications (2)

Publication Number Publication Date
RU2016127226A RU2016127226A (ru) 2018-01-23
RU2683940C1 true RU2683940C1 (ru) 2019-04-03

Family

ID=50000414

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2016127226A RU2683940C1 (ru) 2013-12-09 2014-12-08 Производные имидазотиазола в качестве модуляторов активности tnf

Country Status (11)

Country Link
US (1) US10273247B2 (cg-RX-API-DMAC7.html)
EP (1) EP3080133B1 (cg-RX-API-DMAC7.html)
JP (1) JP6483700B2 (cg-RX-API-DMAC7.html)
CN (1) CN105814065B (cg-RX-API-DMAC7.html)
BR (1) BR112016011522B1 (cg-RX-API-DMAC7.html)
CA (1) CA2930912C (cg-RX-API-DMAC7.html)
ES (1) ES2743190T3 (cg-RX-API-DMAC7.html)
GB (1) GB201321731D0 (cg-RX-API-DMAC7.html)
RU (1) RU2683940C1 (cg-RX-API-DMAC7.html)
TR (1) TR201910983T4 (cg-RX-API-DMAC7.html)
WO (1) WO2015086504A1 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201321735D0 (en) * 2013-12-09 2014-01-22 Ucb Pharma Sa Therapeutic Agents
UY36629A (es) 2015-04-17 2016-11-30 Abbvie Inc Indazolonas como moduladores de la señalización de tnf
EP3286195A1 (en) 2015-04-17 2018-02-28 AbbVie Inc. Indazolones as modulators of tnf signaling
AR104291A1 (es) 2015-04-17 2017-07-12 Abbvie Inc Moduladores tricíclicos de la señalización por tnf
GB201510758D0 (en) 2015-06-18 2015-08-05 Ucb Biopharma Sprl Novel TNFa structure for use in therapy
GB201621907D0 (en) 2016-12-21 2017-02-01 Ucb Biopharma Sprl And Sanofi Antibody epitope
EP3824906A1 (en) 2016-12-21 2021-05-26 Amgen Inc. Anti-tnf alpha antibody formulations
TW201920202A (zh) * 2017-08-17 2019-06-01 瑞士商愛杜西亞製藥有限公司 吲哚胺2,3-二氧酶及/或色胺酸2,3-二氧酶的抑制劑
US20240002401A1 (en) * 2020-11-16 2024-01-04 Guangzhou Henovcom Bioscience Co., Ltd. Imidazothiazole compounds, pharmaceutical compositions, and uses thereof

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0463212A1 (en) * 1990-06-27 1992-01-02 Nikken Chemicals Co., Ltd. Imidazo[2,1-b]thiazole compound anti-ulcer agent containing the same
US5552422A (en) * 1995-01-11 1996-09-03 Merck Frosst Canada, Inc. Aryl substituted 5,5 fused aromatic nitrogen compounds as anti-inflammatory agents
WO2001064674A1 (en) * 2000-03-01 2001-09-07 Janssen Pharmaceutica N.V. 2,4-disubstituted thiazolyl derivatives
WO2004110990A2 (en) * 2003-05-15 2004-12-23 Arqule, Inc. Imidazothiazoles and imidazoxazole derivatives as inhibitors of p38
RU2450010C2 (ru) * 2006-03-10 2012-05-10 Грюненталь Гмбх ЗАМЕЩЕННЫЕ ИМИДАЗО[2,1-b]ТИАЗОЛЫ И ИХ ПРИМЕНЕНИЕ ДЛЯ ПРИГОТОВЛЕНИЯ ЛЕКАРСТВЕННЫХ СРЕДСТВ
WO2013186229A1 (en) * 2012-06-11 2013-12-19 Ucb Pharma S.A. Tnf -alpha modulating benzimidazoles

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5577987A (en) 1994-07-07 1996-11-26 Precise Exercise Equipment Co. Abdominal exerciser device
JP2002167389A (ja) * 2000-09-20 2002-06-11 Nikken Chem Co Ltd 新規チアゾールニ環化合物
CA2523336A1 (en) * 2003-04-30 2004-11-11 Merck Frosst Canada Ltd. 8-(3-biaryl)phenylquinoline phosphodiesterase-4-inhibitors
CN1823072A (zh) * 2003-05-15 2006-08-23 艾科尔公司 作为p38抑制剂的咪唑并噻唑和咪唑并噁唑衍生物
WO2011132048A1 (en) 2010-04-19 2011-10-27 Glenmark Pharmaceutical S.A. Heteroaryl compounds as pde10a inhibitors
ES2689429T3 (es) 2012-07-13 2018-11-14 Ucb Biopharma Sprl Derivados de imidazopiridina como moduladores de actividad de TNF
GB201212513D0 (en) 2012-07-13 2012-08-29 Ucb Pharma Sa Therapeutic agents

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0463212A1 (en) * 1990-06-27 1992-01-02 Nikken Chemicals Co., Ltd. Imidazo[2,1-b]thiazole compound anti-ulcer agent containing the same
US5552422A (en) * 1995-01-11 1996-09-03 Merck Frosst Canada, Inc. Aryl substituted 5,5 fused aromatic nitrogen compounds as anti-inflammatory agents
WO2001064674A1 (en) * 2000-03-01 2001-09-07 Janssen Pharmaceutica N.V. 2,4-disubstituted thiazolyl derivatives
WO2004110990A2 (en) * 2003-05-15 2004-12-23 Arqule, Inc. Imidazothiazoles and imidazoxazole derivatives as inhibitors of p38
RU2450010C2 (ru) * 2006-03-10 2012-05-10 Грюненталь Гмбх ЗАМЕЩЕННЫЕ ИМИДАЗО[2,1-b]ТИАЗОЛЫ И ИХ ПРИМЕНЕНИЕ ДЛЯ ПРИГОТОВЛЕНИЯ ЛЕКАРСТВЕННЫХ СРЕДСТВ
WO2013186229A1 (en) * 2012-06-11 2013-12-19 Ucb Pharma S.A. Tnf -alpha modulating benzimidazoles

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
ALDO ANDREANI et al.: "Effects of new ubiquinone-imidazo[2,1-bthiazoles on mitochondrial complex I (NADH-ubiquinone reductase) and on mitochondrial permeability transition pore", BIOORGANIC & MEDICINAL CHEMISTRY, 2004, vol.12, p.5525-5532. YI-SHUO ZHU et al.: "Palladium-catalyzed microwave-assisted direct arylation of imidazo[2,1-b]thiazoles with arul bromides: synthesis and mechanistic study", ORGANIC & BIOMOLECULAR CHEMISTRY, 2014, vol.12, no.30, page 5773. *
JOS SEBASTIN BARRADAS et al.: "Synthesis of imidazo[2,1-b]thiazoles linked to an unprotected carbohydtate moiety", CARBOHYDRATE RESEARCH, 2012, vol.355, pages 79-86. *
ROBERTA BUDRIESI et al.: "Cystic Fibrosis: A new target for 4-imidazo[2,1-b]thiazole-1,4-dihydropyridines", JOURNAL OF MEDICINAL CHEMISTRY, 2011, vol.54, no.11, pages 3885-3894. *
STEVE D.FIDANZE et al.: "Imidazo[2,1-b]thiazoles: Multitargeted inhibitors of both the insulin-like growth factor receptor and members of the epidermal growth factor family of receptor tyrosine kinases", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, vol.20, no.8, pages 2452-2455. *
STEVE D.FIDANZE et al.: "Imidazo[2,1-b]thiazoles: Multitargeted inhibitors of both the insulin-like growth factor receptor and members of the epidermal growth factor family of receptor tyrosine kinases", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, vol.20, no.8, pages 2452-2455. JOS SEBASTIN BARRADAS et al.: "Synthesis of imidazo[2,1-b]thiazoles linked to an unprotected carbohydtate moiety", CARBOHYDRATE RESEARCH, 2012, vol.355, pages 79-86. ROBERTA BUDRIESI et al.: "Cystic Fibrosis: A new target for 4-imidazo[2,1-b]thiazole-1,4-dihydropyridines", JOURNAL OF MEDICINAL CHEMISTRY, 2011, vol.54, no.11, pages 3885-3894. База Данных REGISTRY CHEMICAL ABSTRACT SERVICE, *
YI-SHUO ZHU et al.: "Palladium-catalyzed microwave-assisted direct arylation of imidazo[2,1-b]thiazoles with arul bromides: synthesis and mechanistic study", ORGANIC & BIOMOLECULAR CHEMISTRY, 2014, vol.12, no.30, page 5773. *
База Данных REGISTRY CHEMICAL ABSTRACT ALDO ANDREANI et al.: "Effects of new ubiquinone-imidazo[2,1-bthiazoles on mitochondrial complex I (NADH-ubiquinone reductase) and on mitochondrial permeability transition pore", BIOORGANIC & MEDICINAL CHEMISTRY, 2004, vol.12, p.5525-5532. *

Also Published As

Publication number Publication date
BR112016011522A2 (cg-RX-API-DMAC7.html) 2017-08-08
EP3080133A1 (en) 2016-10-19
US20160376290A1 (en) 2016-12-29
ES2743190T3 (es) 2020-02-18
CN105814065B (zh) 2018-11-23
TR201910983T4 (tr) 2019-08-21
CN105814065A (zh) 2016-07-27
JP6483700B2 (ja) 2019-03-13
GB201321731D0 (en) 2014-01-22
US10273247B2 (en) 2019-04-30
WO2015086504A1 (en) 2015-06-18
RU2016127226A (ru) 2018-01-23
EP3080133B1 (en) 2019-07-10
CA2930912A1 (en) 2015-06-18
BR112016011522B1 (pt) 2022-10-25
JP2016539968A (ja) 2016-12-22
CA2930912C (en) 2021-10-26

Similar Documents

Publication Publication Date Title
RU2696270C1 (ru) Производные тетрагидроимидазопиридина в качестве модуляторов активности tnf
RU2677696C1 (ru) Производные бензотриазола в качестве модуляторов активности tnf
RU2683318C1 (ru) Производные имидазопиридина в качестве модуляторов активности tnf
RU2695664C1 (ru) Производные имидазопиридина в качестве модуляторов активности tnf
RU2691629C1 (ru) Производные имидазопиримидина в качестве модуляторов активности tnf
RU2678305C1 (ru) Производные имидазопиридина в качестве модуляторов активности tnf
RU2677699C1 (ru) Производные имидазотриазина в качестве модуляторов активности tnf
RU2684641C1 (ru) Производные пиразолопиридина в качестве модуляторов активности tnf
RU2679609C1 (ru) Производные имидазопиридазина в качестве модуляторов активности tnf
RU2684637C1 (ru) Производные тетрагидробензимидазола в качестве модуляторов активности tnf
RU2684635C1 (ru) Производные тетрагидроимидазопиридина в качестве модуляторов активновти tnf
RU2684644C1 (ru) Производные пурина в качестве модуляторов активности tnf
RU2686117C1 (ru) Конденсированные производные имидазола и пиразола в качестве модуляторов активности tnf
RU2677697C1 (ru) Производные триазолопиридина в качестве модуляторов активности tnf
RU2696275C1 (ru) Производные имидазопиридина в качестве модуляторов активности tnf
RU2677698C1 (ru) Производные триазолопиридазина в качестве модуляторов активности tnf
US10273247B2 (en) Imidazothiazole derivatives as modulators of TNF activity
RU2697090C1 (ru) Производные тетрагидроимидазопиридина в качестве модуляторов активности tnf